Ligand Pharmaceuticals
LGND
#3296
Rank
S$5.88 B
Marketcap
S$293.43
Share price
3.22%
Change (1 day)
124.80%
Change (1 year)

Earnings for Ligand Pharmaceuticals (LGND)

Earnings in 2025 (TTM): S$0.20 Billion

According to Ligand Pharmaceuticals's latest financial reports the company's current earnings are S$0.26 Billion. , an increase over its 2024 earnings that were of S$7.1 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Ligand Pharmaceuticals from 1994 to 2025

Annual earnings

Year Earnings Change
2025 S$0.20 B2848.57%
2024 S$7.1 M-91.37%
2023 S$82.29 M-7.59%
2022 S$89.05 M4%
2021 S$85.62 M296.42%
2020 S$21.6 M-97.97%
2019 S$1.06 B275.62%
2018 S$0.28 B237.48%
2017 S$84.01 M49.05%
2016 S$56.36 M55.41%
2015 S$36.26 M36.87%
2014 S$26.49 M29.59%
2013 S$20.44 M1309.35%
2012 S$1.45 M-43.97%
2011 S$2.58 M-113.19%
2010 -S$19.64 Million59.86%
2009 -S$12.29 Million-61.33%
2008 -S$31.77 Million-58.75%
2007 -S$77 Million20.52%
2006 -S$63.89 Million81.27%
2005 -S$35.25 Million
2003 -S$24.54 Million-20.6%
2002 -S$30.91 Million4.38%
2001 -S$29.61 Million-48.83%
2000 -S$57.86 Million-19.74%
1999 -S$72.09 Million-19.06%
1998 -S$89.06 Million126.71%
1997 -S$39.29 Million-5.83%
1996 -S$41.72 Million136.23%
1995 -S$17.66 Million-33.97%
1994 -S$26.75 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
S$33.24 B 15,772.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$13.55 B 6,370.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$39.82 B 18,916.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$11.62 B 5,451.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
-S$0.65 Billion-410.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$16.82 B 7,935.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$12.27 B 5,763.45%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
S$12.80 B 6,016.63%๐Ÿ‡ฌ๐Ÿ‡ง UK
Spectrum Pharmaceuticals
SPPI
-S$79.18 Million-137.81%๐Ÿ‡บ๐Ÿ‡ธ USA